NCT06746831View on ClinicalTrials.gov

Methamphetamine Isomer Pharmacology in Humans

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions

Methamphetamine

Interventions

DRUG

S-(+)-methamphetamine

15 mg

DRUG

R-(-)-methamphetamine

15 mg

DRUG

1:1 racemic mixture of two isomers

15 mg R-Meth + 15 mg S-Meth

Trial Locations (1)

53705

University of Wisconsin, Madison

All Listed Sponsors

collaborator

U.S. Department of Justice

FED

lead

University of Wisconsin, Madison

OTHER